NewLeaf Symbiotics, Inc.

NewLeaf Symbiotics, Inc.

NewLeaf Symbiotics, Inc.

NewLeaf Symbiotics develops and commercializes the bacteria found in PinkPigmented Facultative Methylotrophs.
Type
B2c
Founded
1999
Raised
$101.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$20,000,000
Venture capital (Series D) - 2020
RockPort Capital S2G Ventures Otter Capital +2
$30,000,000
Venture capital (Series C) - 2017
Pangaea Ventures S2G Ventures Monsanto Growth Ventures +1
Team Size
10+
Employees
$20,000,000 Venture capital (Series D)
AgFunderNews

NewLeaf Symbiotics raises $20m Series D to expand offerings to broadacre row crops

$30,000,000 Venture capital (Series C)
PE HUB

Pangaea invests in NewLeaf Symbiotics' $30 mln Series C

Funding
$24,000,000 Venture capital (Series C)
businesswire , PE HUB , FinSMEs

Ag Biotech Company NewLeaf Symbiotics Announces $24MM C Round Financing